Current Category is: Diabetes | Select Another Category
Go Back To Category Homepage | View Category Sitemap
Free Information
Home   |   Search   |   Categories   |   Links   |   About Us   |   Contact Us


Ascensia Breeze Glucometer Rated


Simple Testing Over and Over

* simple and easy testing. Simple single-function buttons are easy-to-use and easy to understand

* No more having to use individual test strips. You have One easy-to-load autodisc which includes 10 individual test strip.

* No coding required

* Glucometer has a comfortable shape. Fits right in the palm of your hand. Glucose blood sugar machine is stable for table-top testing

* Get accurate results fast.

* You need just a very small blood drop because the test strip automatically draws the blood right on the strip - that's what Bayer calls the "Sip-in Sampling"®

* Saves information up to 100 tests

* You can download the meter's information with your computer using the Ascensia Winglucofacts Diabetes Management Software for simple and flexible diabetes data management

* Ascensia Glucometers has been cleared for multiple site testing. You have more choice and flexibility about where you prefer to test.

* You can test on your finger, forearm, palm, abdomen or thigh -- it's up to you. However, make sure you talk to your healthcare professional first to make sure that alternate site testing is right for you.

* Simple to use lancet device.

Pros and Cons of Ascensia Breeze Glucose Monitor

Pros:

**Simple to use because you don't have to change the strips everytime you want to test your blood sugar

**Simple to use lancet device.

**With a pull forward and push back method to release the strip it is an easy way to release the strip.

**Only needs a tiny drop of blood.

Cons:

**If you want to do alternative testing, you have to call Bayer and they will send you a special lancing device so you can use alternative testing. You do have to pay like a $4.95 S&H fee. Or they include a $25 coupon you can take to your pharmcacy to get the special lancing device. And that's if the pharmacy has it available.

** That means once you have your blood glucose machine, you can't start testing on alternative sites until you have the special lancing device.

**To open the machine at the top can be confusing initially and a little difficult if you have arthritis. Though most patients do get the hang of it after a few times.

**The pull and push back method to release the strip again may have some arthritis patients having some difficulty but most patients are able to do this in a few tries.

Overall, this is a great glucomenter. If it weren't that you have to call Bayer to get the special lancing device, I would rate this machine a 9. But because of this factor, again, like the Accucheck Compact, this glucometer would be rated an 8.

Either machine, the Accucheck Compack and the Ascencia Breeze both are high tech glucose meter that really do help the diabetes perform simpler blood sugar results and feel both of these are the best glucometers on the market now.

Here is the pdf for the instruction for the Ascensia Breeze. By the way, Bayer makes the Ascensia Breeze. Definitely shocked me when I started using this glucose machine on my patients.

English:
http://www.bayercarediabetes.com/prodServ/custService/pdf/breeze_span.pdf

Spanish:
http://www.bayercarediabetes.com/prodServ/custService/pdf/breeze_eng.pdf

Copyright 2005 Fern Kuhn, RN
Specializing in Diabetes
http://www.diabetestestingcenter.com
http://www.gastricbypassreviews.info
http://www.anxietydisordernews.info

You may reprint this article as long as you keep the links active.


MORE RESOURCES:

New York Daily News

Death Rate Dropping for People With Diabetes
WebMD
By Denise Mann May 22, 2012 -- New research shows that people with diabetes are living longer, and this is likely due to heart-healthy habits and tighter control of blood sugar levels. Many people may only associate diabetes with vision loss, ...
US Sees Drop in Deaths Linked to DiabetesU.S. News & World Report
Death rate drops among Americans with diabetes -CDCReuters
Study: People are living longer with diabetesNew York Daily News
MedPage Today -msnbc.com (blog) -MarketWatch (press release)
all 506 news articles »


Eli Lilly: Diabetes Drug Meets Cardiovascular Goals
Wall Street Journal
(LLY) said dulaglutide, an investigational treatment for Type 2 diabetes, met a primary endpoint for blood pressure and heart rate effects in a 16-week study. Dulaglutide, which is being studied as a once-weekly treatment for diabetes, was administered ...
Eli Lilly's diabetes drug meets mid-stage trial goalReuters
Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on ...PR Newswire (press release)
Lilly posts clean safety data on PhIII diabetes blockbuster hopefulFierceBiotech
NASDAQ
all 25 news articles »


Diabetes Drug Target Identified
Science Daily (press release)
ScienceDaily (May 21, 2012) — New research from the University of Cincinnati (UC) points to the naturally produced protein apolipoprotein A-IV (apoA-IV) as a potential target for a new diabetes therapeutic. Patrick Tso, PhD, professor in the UC ...
Apofore Founder Publishes Studies Identifying Apolipoprotein A-IV as New ...MarketWatch (press release)

all 4 news articles »


The Guardian

Diabetes timebomb: Only half of NHS patients receiving acceptable care
The Independent
Sweeping variations in standards of care for diabetic patients is costing thousands of lives and wasting tens of millions of pounds every year, the government's spending watchdog reveals. Less than half the people with diabetes in England receive all ...
Diabetes care 'has been failing for decade'BBC News
Report reveals diabetes 'lottery'The Press Association
NHS failings lead to deaths of 24000 diabetics each year, says reportThe Guardian
ITV News -Get Bracknell -The Sun
all 7 news articles »


Medgadget.com

Diabetes Design Demo Day Semi-Finalist: N4A Diabetes Care Center
Medgadget.com
by Nicholas Genes on May 22, 2012 • 2:26 pm Among all the semi-finalists for Sanofi's Data Design Diabetes Demo Day, we think N4A Diabetes Care Center was the most unexpected and confusing. N4A dates back to 1960′s legislation on aging, and is a loose ...
Beaufort man advances to semifinals in diabetes innovation challengeHilton Head Island Packet

all 6 news articles »


A Sweet Life

Novo Nordisk diabetes drug gets broader approval
CBS News
NEW YORK — Danish drugmaker Novo Nordisk A/S said Tuesday that the Food and Drug Administration granted an additional marketing approval for its diabetes drug Levemir. Novo Nordisk says Levemir is now approved for use in children with type 1 diabetes ...
FDA Approves Levemir® for Expanded Use in Children Two to Five Years of Age ...MarketWatch (press release)
Novo Nordisk Diabetes Drug Approved For ToddlersInvestor's Business Daily
Novo Nordisk's Levemir Insulin Approved for Use in Children as Young as TwoA Sweet Life
Family Practice News Digital Network
all 15 news articles »


Diabetes class being offered in Fayette
Pittsburgh Tribune-Review
By Daily Courier Penn State Cooperative Extension, Fayette County, is offering a low-cost class titled "Dining with Diabetes: A Program for Adults with Diabetes and their Families" to teach those with type 2 diabetes how to manage their disease.



Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Diabetic ...
MarketWatch (press release)
BOSTON, May 22, 2012 /PRNewswire via COMTEX/ -- Rhythm announced today the results of a Phase 1b clinical trial of RM-131, the company's novel ghrelin agonist for the treatment of diabetic gastroparesis. The trial demonstrated that RM-131 greatly ...

and more »


Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For ...
MarketWatch (press release)
WESTPORT, Conn., May 22, 2012 /PRNewswire via COMTEX/ -- Valeritas, the maker of V-Go(TM) Disposable Insulin Delivery Device, a new, simple disposable device for the delivery of insulin designed especially for adults with type 2 diabetes, has selected ...

and more »


Medgadget.com

Diabetes Design Demo Day Semi-Finalist: GreenDot
Medgadget.com
by Nicholas Genes on May 22, 2012 • 12:38 pm Next up in our coverage of semi-finalists for Sanofi's Data Design Diabetes Demo Day is GreenDot, which used to be called Diabetes 3.0 (good idea on the name change, guys!) GreenDot was started by two UCSF ...


Google News

Home   |   Sitemap   |   Disclaimer   |   Privacy   |   Contact Us

© COPYRIGHT 2011 BRAINBELLY.COM